VenaFlux Solutions offers a range of packages to fit different budgets, empowering researchers with innovative tools

Antiplatelet therapy reduces stroke and heart attack recurrence risk, but thrombotic diseases remain a leading cause of death

Post-COVID Syndrome (PCS) involves long-lasting, unexplained symptoms after SARS-CoV-2 infection, impacting quality of life.

8 capillaries in parallel which can be coated with a protein or seeded with cells or microbes and subsequent study of drug interaction

Adhesion of the thrombus to the vein wall | thrombus contraction and spontaneous lysis of the thrombus | mechanical thrombectomy (MT)

precision microfluidic pumps | Pulse free syringe pumps | Multiple independent channel pumping | Patented active flow control

Quantify cell adhesion, rolling, migration, cell-cell adhesion, platelet aggregation, thrombi formation - all under shear flow

Quantify cell adhesion, rolling, migration, cell-cell adhesion, platelet aggregation, thrombi formation - all under shear flow.

On this World Thrombosis Day and in advance of World Stroke Day, taking place on 29th October, we’d like to shine a light on a paper recentl

The researchers of this study focused on how recruited platelets interact with neutrophils and whether this promotes the onset of Deep Vein